Technology News and Research

RSS

Gene detectives discover culprit for type 1 diabetes

Researchers at the Children's Hospital of Philadelphia and McGill University in Montreal have discovered a gene they believe is the culprit in a person developing type 1 diabetes.

16 Jul 2007

Paint helps surgeons see where a tumor begins and ends

A tumor paint developed by researchers at Seattle Children's Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.

16 Jul 2007

New genomics-based technology

Bruce S. Gillis, M.D., M.P.H., a medical toxicologist and CEO of the research group, The Cytokine Institute, will present a tutorial on a new genomics-based technology, msds1(TM).

16 Jul 2007

Real-time 3-D ultrasound in nerve blockade speeds patient recovery

Mayo Clinic physicians have adapted real-time 3-D ultrasound imaging devices -- including one designed to look at an infant's heart -- so that they can watch as they use a needle filled with anesthetic to numb individual nerves located inches under the skin.

16 Jul 2007

New gene found for type 1 diabetes in children

Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes.

16 Jul 2007

ACMG recognizes progress made in newborn screening

In support of the latest March of Dimes Newborn Screening Report Card, the American College of Medical Genetics (ACMG) strongly urges every state to require complete testing of all newborns for a 'core panel' of genetic and congenital conditions.

16 Jul 2007

Hope for cure for insulin-dependent diabetes

A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients.

16 Jul 2007

New DNA sequencing technology at University of Liverpool

Unique technology, that uses the enzymes of fireflies to read the genetic code of DNA, has been installed at the University of Liverpool.

13 Jul 2007

Chemically-modified mitochondrial toxin could lead to a new molecularly-targeted chemo drug

A chemically-modified version of a mitochondrial toxin long used to control species of invasive fish in lakes has been found to selectively inhibit two "survival proteins" in cancer cells.

12 Jul 2007

Global Med Technologies awarded new patent for transfusion software

Global Med Technologies has announced that the United States Patent and Trademark Office will be issuing a patent for SafeTrace Tx, its proprietary transfusion software, which is located at more than 337 sites in the United States and abroad.

12 Jul 2007

Chemotherapy may benefit all women with a BRCA1 mutation

Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.

12 Jul 2007

Bavarian Nordic granted new European patent on modified vaccinia virus Ankara

The European Patent Organisation (EPO) has granted a patent to Bavarian Nordic which further strengthens its intellectual property position on MVA in Europe.

12 Jul 2007

New use for a cell toxin found to inhibit survival proteins in cancer cells

A chemically-modified version of a mitochondrial toxin long used to control species of invasive fish in lakes has been found to selectively inhibit two "survival proteins" in cancer cells.

11 Jul 2007

Sigma-Aldrich launches Imprint DNA Modification kit

Sigma-Aldrich has announced the launch of the Imprint DNA Modification kit.

11 Jul 2007

Signalife awarded new U.S. patent

Signalife, Inc. has announced that The United States Patent and Trademark Office has awarded the Company a new and important patent, which the Company has now added to its significant intellectual property portfolio.

11 Jul 2007

Luminex and Exiqon sign distribution agreement for microRNA products

Luminex Corporation and Exiqon A/S have announced the execution of a distribution agreement for the FlexmiR line of products co-developed by the companies in 2006.

From Luminex 11 Jul 2007

Myomo receives FDA approval to market e100 NeuroRobotic System

Myomo, Inc. has announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals.

11 Jul 2007

Abiogen licenses RFB4 antibody from Cancer Research Technology

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, today announces it has agreed an exclusive worldwide licence with Abiogen Pharma S.p.A. (Italy).

11 Jul 2007

3-D microscopic views of tiny mouse brains available online

A multi-institutional consortium including Duke University has created startlingly crisp 3-D microscopic views of tiny mouse brains - unveiled layer by layer - by extending the capabilities of conventional magnetic resonance imaging.

10 Jul 2007

Magnetic nano tweezers show how cancer drug works

The annoying bulges of an over-wound telephone cord that shorten its reach and limit a caller's motion help to explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators at St. Jude Children's Research Hospital and Delft University of Technology.

10 Jul 2007